Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
Francesco Iorio(Human Technopole), Mathew J. Garnett(Wellcome Sanger Institute), Piers Wilkinson(Wellcome Sanger Institute), Sarah Harper(Wellcome Sanger Institute), Rizwan Ansari(Wellcome Sanger Institute), Charlotte Beaver(Wellcome Sanger Institute), Fiona M. Behan(Age UK), Rebecca Shepherd(Lancaster University), Elisabeth Chen(Wellcome Sanger Institute), Rachel Pooley(Wellcome Sanger Institute), Shriram G. Bhosle(Wellcome Sanger Institute), Emanuel Gonçalves(European Bioinformatics Institute), Euan A. Stronach(Age UK), Kosuke Yusa(Kyoto University), Adam P. Butler(Wellcome Sanger Institute), Julio Sáez-Rodríguez(European Bioinformatics Institute)
Cited by 144
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k